• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Secondary immunodeficiencies with predominant antibody deficiency: multidisciplinary perspectives of Polish experts.以抗体缺陷为主的继发性免疫缺陷:波兰专家的多学科观点
Cent Eur J Immunol. 2020;45(3):334-341. doi: 10.5114/ceji.2020.101265. Epub 2020 Nov 1.
2
AAOA allergy primer: immunodeficiency.美国眼科过敏学会过敏入门:免疫缺陷
Int Forum Allergy Rhinol. 2014 Sep;4 Suppl 2:S74-8. doi: 10.1002/alr.21379.
3
Immunoglobulin replacement therapy in secondary hypogammaglobulinemia.继发性低丙种球蛋白血症的免疫球蛋白替代治疗。
Front Immunol. 2014 Dec 8;5:626. doi: 10.3389/fimmu.2014.00626. eCollection 2014.
4
The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.继发性抗体缺陷的扩展领域:病因、诊断和治疗。
Front Immunol. 2019 Feb 8;10:33. doi: 10.3389/fimmu.2019.00033. eCollection 2019.
5
Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.皮下注射免疫球蛋白治疗淋巴增殖性疾病及利妥昔单抗相关的继发性低丙种球蛋白血症:61例患者的单中心经验
Haematologica. 2014 Jun;99(6):1101-6. doi: 10.3324/haematol.2013.101261. Epub 2014 Mar 28.
6
Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab.利妥昔单抗治疗免疫性血小板减少性紫癜后暴露的常见可变免疫缺陷。
BMC Hematol. 2013 Apr 11;13(1):4. doi: 10.1186/2052-1839-13-4.
7
Clinical and experimental treatment of primary humoral immunodeficiencies.原发性体液免疫缺陷的临床与实验性治疗
Clin Exp Immunol. 2024 Apr 23;216(2):120-131. doi: 10.1093/cei/uxae008.
8
Nursing guidelines for administration of immunoglobulin replacement therapy.免疫球蛋白替代疗法的护理指南。
J Infus Nurs. 2013 Jan-Feb;36(1):58-68. doi: 10.1097/NAN.0b013e3182798af8.
9
Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.体液免疫缺陷:感染风险及免疫球蛋白替代疗法的益处
Transfusion. 2018 Dec;58 Suppl 3(Suppl 3):3056-3064. doi: 10.1111/trf.15020.
10
Smallpox vaccination and adverse reactions. Guidance for clinicians.天花疫苗接种与不良反应。临床医生指南。
MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28.

引用本文的文献

1
Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations.血液系统恶性肿瘤患者继发性免疫缺陷管理的当前方法:西班牙专家共识推荐
J Clin Med. 2023 Oct 4;12(19):6356. doi: 10.3390/jcm12196356.
2
Increased Access to Immunoglobulin Replacement Therapy for Patients with Primary Immunodeficiency in Poland Based on Clinical Usage Data of Immunoglobulin G over a 5-Year Period.基于5年期间免疫球蛋白G的临床使用数据,波兰原发性免疫缺陷患者获得免疫球蛋白替代疗法的机会增加。
J Clin Med. 2023 Mar 22;12(6):2431. doi: 10.3390/jcm12062431.
3
Secondary Dysgammaglobulinemia in Children with Hematological Malignancies Treated with Targeted Therapies.靶向治疗治疗血液系统恶性肿瘤儿童的继发性低丙种球蛋白血症。
Paediatr Drugs. 2021 Sep;23(5):445-455. doi: 10.1007/s40272-021-00461-3. Epub 2021 Jul 22.

本文引用的文献

1
Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review.免疫球蛋白替代治疗在自身免疫性风湿病 B 细胞靶向治疗后的继发免疫缺陷:系统文献回顾。
Autoimmun Rev. 2019 May;18(5):535-541. doi: 10.1016/j.autrev.2019.03.010. Epub 2019 Mar 4.
2
Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies.血液恶性肿瘤中继发性免疫缺陷的临床实践现状和挑战。
Eur J Haematol. 2019 Jun;102(6):447-456. doi: 10.1111/ejh.13223. Epub 2019 Mar 24.
3
The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.继发性抗体缺陷的扩展领域:病因、诊断和治疗。
Front Immunol. 2019 Feb 8;10:33. doi: 10.3389/fimmu.2019.00033. eCollection 2019.
4
The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments.八因子浓缩剂和免疫球蛋白在血液系统恶性肿瘤相关免疫缺陷中的应用:来自法国21个血液科的前瞻性研究
Hematology. 2019 Dec;24(1):173-182. doi: 10.1080/10245332.2018.1538001. Epub 2018 Nov 20.
5
A Prospective Observational Study of Hypogammaglobulinemia in the First Year After Lung Transplantation.肺移植术后第一年低丙种球蛋白血症的前瞻性观察研究
Transplant Direct. 2018 Jul 12;4(8):e372. doi: 10.1097/TXD.0000000000000811. eCollection 2018 Aug.
6
The first Polish cohort of adult patients with common variable immunodeficiency from 4 specialized centers: do we provide standards of care?来自4个专业中心的首批波兰成年常见可变免疫缺陷患者队列:我们提供了护理标准吗?
Pol Arch Intern Med. 2018 Sep 28;128(9):563-566. doi: 10.20452/pamw.4315. Epub 2018 Aug 16.
7
Efficacy-safety of Facilitated Subcutaneous Immunoglobulin in Immunodeficiency Due to Hematological Malignancies. A Single-Center Retrospective Analysis.血液系统恶性肿瘤所致免疫缺陷中简易皮下注射免疫球蛋白的疗效与安全性。单中心回顾性分析。
Anticancer Res. 2018 Jul;38(7):4187-4191. doi: 10.21873/anticanres.12712.
8
Measurement and interpretation of Salmonella typhi Vi IgG antibodies for the assessment of adaptive immunity.用于评估适应性免疫的伤寒沙门氏菌Vi IgG抗体的检测与解读。
J Immunol Methods. 2018 Aug;459:1-10. doi: 10.1016/j.jim.2018.05.013. Epub 2018 May 22.
9
Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysis.免疫球蛋白预防在降低造血干细胞移植临床并发症中的有效性:一项系统评价和荟萃分析。
Transfusion. 2018 Oct;58(10):2437-2452. doi: 10.1111/trf.14656. Epub 2018 May 16.
10
Pneumococcal conjugate vaccine triggers a better immune response than pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia A randomized study by the Swedish CLL group.肺炎球菌结合疫苗在慢性淋巴细胞白血病患者中引发的免疫应答优于肺炎球菌多糖疫苗:一项由瑞典 CLL 研究组开展的随机研究。
Vaccine. 2018 Jun 14;36(25):3701-3707. doi: 10.1016/j.vaccine.2018.05.012. Epub 2018 May 7.

以抗体缺陷为主的继发性免疫缺陷:波兰专家的多学科观点

Secondary immunodeficiencies with predominant antibody deficiency: multidisciplinary perspectives of Polish experts.

作者信息

Jahnz-RÓŻyk Karina, WiĘsik-Szewczyk Ewa, RoliŃski Jacek, Siedlar Maciej, JĘdrzejczak WiesŁaw, Sydor Wojciech, Tomaszewska Agnieszka

机构信息

Department of Internal Medicine, Pneumonology, Allergology and Clinical Immunology, Central Clinical Hospital of the Ministry of National Defense, Military Institute of Medicine, Warsaw, Poland.

Department of Clinical Immunology, Medical University of Lublin, Lublin, Poland.

出版信息

Cent Eur J Immunol. 2020;45(3):334-341. doi: 10.5114/ceji.2020.101265. Epub 2020 Nov 1.

DOI:10.5114/ceji.2020.101265
PMID:33437186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7790006/
Abstract

At present, secondary immune deficiencies have become a clinical problem, recognized in different specialties. The aim of this paper was to increase awareness and support the need for screening at-risk populations. Secondary immune deficiencies result in variety of conditions, but not all of them require immunoglobulin replacement therapy, as specific antibody response might be preserved. Moreover, the management of secondary immune deficiencies vary between countries and different medical disciplines. This literature review presents the most common causes and clinical presentation of secondary immunodeficiencies with predominant impaired antibody production. We present diagnostic guidelines for patients at-risk, with an emphasis on the role of prophylactic vaccination as a treatment and diagnostic tool. This review considers the specificity and disparities of the Polish healthcare system and ultimately, suggests that management teams should include a clinical immunologist experienced in the treatment of humoral immunodeficiencies.

摘要

目前,继发性免疫缺陷已成为一个临床问题,在不同专业领域都得到了认可。本文的目的是提高认识并支持对高危人群进行筛查的必要性。继发性免疫缺陷会导致多种病症,但并非所有病症都需要免疫球蛋白替代疗法,因为特异性抗体反应可能得以保留。此外,继发性免疫缺陷的管理在不同国家和不同医学学科之间存在差异。这篇文献综述介绍了以抗体产生主要受损为特征的继发性免疫缺陷的最常见病因和临床表现。我们为高危患者提供了诊断指南,重点强调了预防性疫苗接种作为一种治疗和诊断工具的作用。本综述考虑了波兰医疗保健系统的特殊性和差异,最终建议管理团队应包括一位在体液免疫缺陷治疗方面经验丰富的临床免疫学家。